NCT06044610

Brief Summary

The primary objective of this study is to analyze smart phone-based Transdermal Optical Imaging (TOI) features to develop a model that can discern hypohydration from euhydration status including 1) a small feasibility study for 24-hour data collection in the general population using passive dehydration or ad libitum fluid intake (GENPOP), 2) an exercise study in moderately active participants in both dehydrated and euhydrated states (EXERCISE). TOI data will be collected alongside standard reference measures of hydration status. This is an exploratory pilot proof of concept study with each subject serving as their own control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 8, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2023

Completed
Last Updated

January 19, 2024

Status Verified

January 1, 2024

Enrollment Period

6 months

First QC Date

September 13, 2023

Last Update Submit

January 18, 2024

Conditions

Keywords

hydrationdehydrationeuhydrationhypohydrationexerciseTransdermal Optical ImagingTOI

Outcome Measures

Primary Outcomes (2)

  • Transdermal optical imaging (TOI) signals

    Blood flow patterns of the face obtained from the video camera on a smart phone

    GENPOP: Before breakfast (~ 8 a.m.), before lunch ~11:30 a.m.), ~3:30 p,m., ~8.a.m. the following day. For EXERCISE, pre and post exercise session allowing for 30 minute cool down period.

  • Standard measurements of hydration status

    Body mass change, urine specific gravity, urine color (1-8 scale), and visual analogue scale to indicate thirst (1=not thirsty at all to 7 very, very thirsty)

    GENPOP: Before breakfast (~ 8 a.m.), before lunch ~11:30 a.m.), ~3:30 p,m., ~8.a.m. the following day. For EXERCISE, pre and post exercise sessions allowing for 30 minute cool down period.

Secondary Outcomes (16)

  • Demographics

    At screening

  • Fitzpatrick scale

    At screening

  • Mood scale

    GENPOP: Before breakfast (~ 8 a.m.), before lunch ~11:30 a.m.), ~3:30 p,m., ~8.a.m. the following day

  • Dietary and fluid intake

    24 hours prior to each visit through end of each study period.

  • EXERCISE only: Rate of perceived exertion (RPE)

    Two 90 minute standard cycling exercise trials separated by approximately 3 to 7 days

  • +11 more secondary outcomes

Study Arms (4)

GENPOP passive dehydration

EXPERIMENTAL

24-hour data collection using a parallel design comparison of TOI blood flow patterns vs. reference methods of hydration status in 10 PEP employees.

Other: GENPOP Passive dehydration (75% reduction in fluid intake

EXERCISE without fluid replacement

EXPERIMENTAL

Randomized cross-over design in 15 moderately active non-employee participants. 90 minutes of standard cycling exercise trial in heat chamber. TOI signals will obtain blood flow patterns from the face to compare against reference methods of dehydration including body mass, urine specific gravity, urine color, and thirst.

Other: EXERCISE without fluid replacement

GENPOP ad lib fluid intake

OTHER

24-hour data collection using a parallel design comparison of TOI blood flow patterns vs. reference methods of hydration status in 10 PEP employees.

Other: GENPOP Ad lib fluid intake

EXERCISE with fluid replacement

OTHER

Randomized cross-over design in 15 moderately active non-employee participants. 90 minutes of standard cycling exercise trial in heat chamber. TOI signals will obtain blood flow patterns from the face to compare against reference methods of dehydration including body mass, urine specific gravity, urine color, and thirst.

Other: EXERCISE with fluid replacement

Interventions

Over 24-hours

GENPOP passive dehydration

Over 24 hours

GENPOP ad lib fluid intake

90-min standard cycling exercise trial in heat chamber

EXERCISE without fluid replacement

90-min standard cycling exercise trial in heat chamber

EXERCISE with fluid replacement

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is male or female
  • If female, subject is not pregnant
  • For GENPOP study subject is 18-65 years of age, inclusive
  • For EXERCISE study subject is 18-50 years of age, inclusive
  • Subject is moderately-trained (engages in moderate-intensity, intermittent, or steady-state exercise at least 3 days per week for at least 1 hour at a time (EXERCISE session participants only)
  • Subject does not smoke (or has quit for at least 6 months)
  • Subject is not taking medication that may interfere with the study
  • Subject has no health conditions that would prevent completion of the trial as indicated on the general health questionnaire (GHQ)
  • Subject is willing to avoid alcohol consumption 24 hours prior to visit(s)
  • Subject is willing to fast overnight (\~8-12 hours)
  • For GENPOP, subject is willing to refrain from vigorous exercise for 48 hours
  • For EXERCISE, subject is willing to refrain from vigorous exercise for 24 hours prior to study visits
  • Subject is willing to eat the exact same food the day prior to each visit to the laboratory
  • Subject is willing to avoid wearing makeup to the study session
  • Subject is willing to shave facial hair if predetermined during the informed consent session it will interfere with TOI measurement
  • +2 more criteria

You may not qualify if:

  • Subject has participated in a clinical trial within the past 30 days
  • Subject has participated in any PepsiCo trial within past 6 months
  • Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk
  • Subject is allergic to alcohol or facial cleansing wipes
  • Subject has a history of anaphylaxis or severe allergic reactions
  • Subjects has a health condition or is taking medication that can be worsened by fluid restriction
  • Subject has asthma or other condition which breathing can become labored during exercise (EXERCISE session participants only)
  • Male subjects with a VO2max \< 42 ml/kg/min and females with a VO2max \< 38 ml/kg/min (EXERCISE session participants only)
  • Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

PepsiCo R&D, Gatorade Sports Science Institute

Valhalla, New York, 10595, United States

Location

PepsiCo R&D, Gatorade Sports Science Institute

Plano, Texas, 75024, United States

Location

MeSH Terms

Conditions

DehydrationMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Water-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Lindsay Baker, PhD

    PepsiCo, Inc. Sports Science

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2023

First Posted

September 21, 2023

Study Start

May 8, 2023

Primary Completion

November 15, 2023

Study Completion

November 15, 2023

Last Updated

January 19, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations